S Eric Nichols

Late last year I began using Motley Fool’s My CAPS as a way for readers to track my new investments and those that fit under the guidelines in my book Taking Charge With Value Investing (McGraw-Hill...... (read more)

Shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) rallied an incredible 31.37% on Thursday after a series of bullish notes that painted a clearer picture for its newly approved (rare-cholesterol...... (read more)

An analyst’s upgrade almost always causes a stock to trend higher. However, those gains can often be a value-trap. In this piece, I am looking at three such stocks; those that I believe are presenting...... (read more)

For the past month, as the markets have created new all-time highs, there have been numerous stocks to rally under the radar. What might have been top-market news in years past has gone unnoticed, and...... (read more)

The post-earning reaction of a stock should not dictate your decision as to whether or not to invest in a company. Sometimes my greatest plays are those that trade lower after earnings, and then sometimes...... (read more)

As the markets traded to new all-time highs there were several stocks seeing massive post-earnings pops on Tuesday. In this piece I am looking at these stocks to determine if the move was warranted and...... (read more)

All three of the major pharmacy companies, Rite Aid Corporation (NYSE:RAD), CVS Caremark Corporation (NYSE:CVS), and Walgreen Company (NYSE:WAG), operate with similar business models, having both retail...... (read more)

Toward the end of 2011, I continuously said “short DDD.” My reason was due to valuation, as 3D Systems Corporation (NYSE:DDD) was among the best performing and most expensive stocks in the technology...... (read more)

In this article I am separating the good from the bad, not in terms of stock performance, but rather fundamentals compared to valuation following earnings. This is one of the best times of the year to...... (read more)